Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE2016, a First-in-Class Allogeneic Anti-EGFR Cell Therapy 2024-02-05 08:00
1